摘要
目的:观察尤瑞克林治疗穿支动脉梗死的效果及对NHISS评分影响。方法:选定笔者所在医院收治的112例穿支动脉梗死患者,研究时段2015年6月-2018年6月,分组原则以随机数字表法为主,分为对照组(56例,采纳临床常规治疗)、研究组(56例,在对照组基础上采纳尤瑞克林治疗),比较NHISS评分、Barthel指数、临床疗效。结果:研究组治疗后NHISS评分低于对照组,差异有统计学意义(P<0.05);研究组治疗后Barthel指数及临床总有效率均高于对照组,差异均有统计学意义(P<0.05)。结论:尤瑞克林可有效改善穿支动脉梗死患者神经功能缺损情况,提高生活自理能力,疗效显著,值得借鉴。
Objective:To observe the efficacy of Urinary Kallidinogenase in treatment of perforating arterial infarction and its effect on NHISS score. Method:A total of 112 patients with perforating arterial infarction admitted to our hospital were selected.During the study period from June 2015 to June 2018,the grouping principle was dominated by random digital table method,and were divided into the control group(56 patients,treated with clinical routine treatment), the study group (56 patients,treated with Urinary Kallidinogenase on the basis of the control group).The NHISS score,Barthel index,clinical efficacy were compared.Result:The NHISS score of the study group was significantly lower than that of the control group(P<0.05).The Barthel index and the total clinical effective rate in the study group were significantly higher than those in the control group(P<0.05).Conclusion:Urinary Kallidinogenase can effectively improve the neurological deficits in patients with perforating arterial infarction,improve the ability of self-care,and has significant curative effect.It is worth learning.
作者
林煜
彭慕立
肖彧
李凤仪
刘国飞
许智能
LIN Yu;PENG Muli;XIAO Yu(People’s Hospital of Gaoyao District in Zhaoqing City,Zhaoqing 526040,China)
出处
《中外医学研究》
2019年第17期39-41,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
尤瑞克林
穿支动脉
梗死
疗效
Urinary Kallidinogenase
Perforating artery
Infarction
Efficacy
